Clinical Trial

A Neurosensory Account of Anxiety and Stress (Study 2)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 12, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-18.
Trial Details
NCT Number NCT07079839
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Institute of Mental Health (NIMH)
Conditions Threat-related Sensory Cortical (SC) Disinhibition, Posttraumatic Stress Disorder (PTSD)
Enrollment 160 participants
Start Date 2025-07-03
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-12